Do transcriptionally silent BCR-ABL cells persist in CML patients in complete remission after BMT?
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F01%3A00002016" target="_blank" >RIV/00023736:_____/01:00002016 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Do transcriptionally silent BCR-ABL cells persist in CML patients in complete remission after BMT?
Original language description
The results of molecular monitoring of BCR-ABL transcript level and molecular chmerism did not confirm the general persistence of transcriptionally silent BCR-ABL cells in amount above 0,01% in CML patients with molecular remission after transplantat, ,,
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NC5902" target="_blank" >NC5902: Molecular markers of chronic myeloid leukemia progression to blast crisis.</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2001
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia
ISSN
—
e-ISSN
—
Volume of the periodical
15
Issue of the periodical within the volume
6
Country of publishing house
GB - UNITED KINGDOM
Number of pages
3
Pages from-to
997-999
UT code for WoS article
—
EID of the result in the Scopus database
—